Trial intelligence / Profile preview

Photodynamic therapy as an adjunct in the treatment of oral candidiasis in ICU patients

RBR-4rq6jrkPhase 2Completed

Sponsor
Departamento de Odontologia
Start
Nov 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of nystatin and fluconazole in oral candidiasis (2 arms), sponsored by Departamento de Odontologia. Started Nov 2025; status: completed.

02

Drugs

nystatinfluconazole
03

Conditions

oral candidiasis

Beyond the preview

Go deeper on RBR-4rq6jrk.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-4rq6jrk.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call